Form 4: Corteva SVP, Gen Counsel and Secretary Fuerer Cornel B Reports Stock Sale
SEC Form 4 Filing
Fuerer Cornel B, SVP, Gen Counsel and Secretary of Corteva, Inc., reported the sale of 39,736 shares of common stock on May 14, 2024, while also exercising stock options for the same amount of shares.
Summary
- On May 14, 2024, Fuerer Cornel B, the SVP, Gen Counsel and Secretary of Corteva, Inc., executed transactions involving the company's common stock.
- Fuerer exercised non-qualified stock options to acquire 39,736 shares at an exercise price of $31.22 per share.
- Simultaneously, Fuerer sold 39,736 shares at a weighted average price of $57.41, with individual sales ranging from $57.40 to $57.44.
- Following these transactions, Fuerer directly owns 126,627.537 shares of Corteva common stock.
- This includes the acquisition of 28.0639 shares pursuant to dividend reinvestment.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company executives. It's common for executives to exercise stock options and sell shares for personal financial management.
Comparison to Industry Standards
- Executive compensation packages often include stock options to align management's interests with those of shareholders.
- The exercise of options and subsequent sale of shares is a common practice among executives in publicly traded companies.
- Similar transactions are regularly reported by executives at companies like Bayer, Syngenta, and BASF, which are major competitors of Corteva in the agricultural sector.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, depending on the overall market perception of the transaction.
- The transaction does not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 05/14/2024 | Date of stock option exercise and stock sale. |
| 05/16/2024 | Date of signature on the Form 4 filing. |
| 02/20/2030 | Expiration date of the non-qualified stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.